LBP-005 DA-1241, a GPR119 agonist, demonstrates hepatoprotective and glucose-regulating effects in a 16-week randomized placebocontrolled trial in presumed metabolic dysfunction-associated steatohepatitis (MASH) patients
Year: 2025
Type: conference-abstract
Source: Journal of Hepatology
Authors: Mi-Kyung Kim, Rohit Loomba, Hyung Heon Kim, Yuna Chae, Robert Homolka, Ji Eun Lee, Kyunghyun Lee, Chris Fang, Byunghee Yoo, Sung-Jin Kim
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410174780